{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:25:01Z","timestamp":1791404701367,"version":"4.3.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"tehran university of medical sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In recent decades, several studies have shown changes in the intestinal microflora among patients with rheumatoid arthritis (RA). Therapeutic measures using probiotics have shown favorable effects on the recovery of these patients. However, most studies have used probiotic supplements. In this study, we aimed to investigate the effect of probiotic cheese consumption on inflammatory and anti-inflammatory factors, disease severity, and symptoms in these patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study is a randomized, double-blind clinical trial, in which forty patients with mild to moderate severity of RA will be randomly allocated to receive either 30 g\/day probiotic cheese (<jats:italic>n<\/jats:italic> = 20) or only low-salt and low-fat cheese without any added probiotic (<jats:italic>n<\/jats:italic> = 20) for 12\u2009weeks. Assessment of anthropometric measures and biochemical indicators, including serum concentrations of high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-\u03b1 (TNF-\u03b1), interleukin-6 (IL-6), and interleukin-10 (IL-10), will be done at the study baseline and end of the trial. In addition, disease severity and disability will be assessed by DAS-28 and the HAQ-DI questionnaire, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Diet is the leading environmental factor affecting the gut microbiota. A prebiotic-rich diet and probiotics might be beneficial in this regard. To the best of our knowledge, the effect of probiotic supplements on inflammation in these patients has widely been assessed; however, there is only one study that examined the effect of probiotic-containing food in these patients. Further studies are needed to investigate the effect of probiotic-containing foods on inflammatory markers and symptoms in patients with RA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Iranian Registry of Clinical Trials <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/fa.irct.ir\/trial\/52436\">IRCT20201120049449N1<\/jats:ext-link>. Registered on 14 February 2021<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06113-2","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T13:02:31Z","timestamp":1645707751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The effect of probiotic cheese consumption on inflammatory and anti-inflammatory markers, disease severity, and symptoms in patients with rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Farzaneh","family":"Asoudeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurosh","family":"Djafarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maassoumeh","family":"Akhalghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Esmaillzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"6113_CR1","doi-asserted-by":"publisher","first-page":"e4035","DOI":"10.7717\/peerj.4035","volume":"5","author":"B Xu","year":"2017","unstructured":"Xu B, Lin J. Characteristics and risk factors of rheumatoid arthritis in the United States: an NHANES analysis. PeerJ. 2017;5:e4035. https:\/\/doi.org\/10.7717\/peerj.4035.","journal-title":"PeerJ."},{"issue":"1","key":"6113_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1196\/annals.1351.019","volume":"1069","author":"TK Kvien","year":"2006","unstructured":"Kvien TK, Uhlig T, \u00d8DEG\u00c5RD S, Heiberg MS. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann NY Acad Sci. 2006;1069(1):212\u201322. https:\/\/doi.org\/10.1196\/annals.1351.019.","journal-title":"Ann NY Acad Sci"},{"issue":"7","key":"6113_CR3","first-page":"1384","volume":"35","author":"F Davatchi","year":"2008","unstructured":"Davatchi F, Jamshidi A-R, Banihashemi AT, Gholami J, Forouzanfar MH, Akhlaghi M, et al. WHO-ILAR COPCORD study (stage 1, urban study) in Iran. J Rheumatol. 2008;35(7):1384\u201390.","journal-title":"J Rheumatol"},{"issue":"9","key":"6113_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1136\/ard.62.9.835","volume":"62","author":"P Stolt","year":"2003","unstructured":"Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis. 2003;62(9):835\u201341. https:\/\/doi.org\/10.1136\/ard.62.9.835.","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"6113_CR5","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1001\/archinte.168.15.1664","volume":"168","author":"KH Costenbader","year":"2008","unstructured":"Costenbader KH, Chang S-C, Laden F, Puett R, Karlson EW. Geographic variation in rheumatoid arthritis incidence among women in the United States. Arch Int Med. 2008;168(15):1664\u201370. https:\/\/doi.org\/10.1001\/archinte.168.15.1664.","journal-title":"Arch Int Med"},{"issue":"11","key":"6113_CR6","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1136\/ard.2004.031666","volume":"64","author":"C Bengtsson","year":"2005","unstructured":"Bengtsson C, Nordmark B, Klareskog L, Lundberg I, Alfredsson L. Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis. 2005;64(11):1588\u201394. https:\/\/doi.org\/10.1136\/ard.2004.031666.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"6113_CR7","first-page":"757","volume":"83","author":"DI Phillips","year":"1998","unstructured":"Phillips DI, Barker DJ, Fall CH, Seckl JR, Whorwood CB, Wood PJ, et al. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J Clin Endocrinol Metab. 1998;83(3):757\u201360.","journal-title":"J Clin Endocrinol Metab"},{"key":"6113_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.mib.2017.01.011","volume":"35","author":"EL Zechner","year":"2017","unstructured":"Zechner EL. Inflammatory disease caused by intestinal pathobionts. Curr Opin Microbiol. 2017;35:64\u20139. https:\/\/doi.org\/10.1016\/j.mib.2017.01.011.","journal-title":"Curr Opin Microbiol"},{"issue":"7","key":"6113_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nrrheum.2016.85","volume":"12","author":"T Van de Wiele","year":"2016","unstructured":"Van de Wiele T, Van Praet JT, Marzorati M, Drennan MB, Elewaut D. How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol. 2016;12(7):398\u2013411. https:\/\/doi.org\/10.1038\/nrrheum.2016.85.","journal-title":"Nat Rev Rheumatol"},{"issue":"24","key":"6113_CR10","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","volume":"375","author":"SV Lynch","year":"2016","unstructured":"Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369\u201379. https:\/\/doi.org\/10.1056\/NEJMra1600266.","journal-title":"N Engl J Med"},{"issue":"1","key":"6113_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4315\/0362-028X-65.1.153","volume":"65","author":"H Kano","year":"2002","unstructured":"Kano H, Kaneko T, Kaminogawa S. Oral intake of Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 prevents collagen-induced arthritis in mice. J Food Protect. 2002;65(1):153\u201360. https:\/\/doi.org\/10.4315\/0362-028X-65.1.153.","journal-title":"J Food Protect"},{"issue":"1","key":"6113_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/J.ENG.2017.01.006","volume":"3","author":"H Pan","year":"2017","unstructured":"Pan H, Li R, Li T, Wang J, Liu L. Whether probiotic supplementation benefits rheumatoid arthritis patients: a systematic review and meta-analysis. Engineering. 2017;3(1):115\u201321. https:\/\/doi.org\/10.1016\/J.ENG.2017.01.006.","journal-title":"Engineering."},{"key":"6113_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.biopha.2018.12.104","volume":"111","author":"D Kothari","year":"2019","unstructured":"Kothari D, Patel S, Kim S-K. Probiotic supplements might not be universally-effective and safe: a review. Biomed Pharmacother. 2019;111:537\u201347. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.104.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"6113_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12602-016-9233-y","volume":"9","author":"S Feizollahzadeh","year":"2017","unstructured":"Feizollahzadeh S, Ghiasvand R, Rezaei A, Khanahmad H, Hariri M. Effect of probiotic soy milk on serum levels of adiponectin, inflammatory mediators, lipid profile, and fasting blood glucose among patients with type II diabetes mellitus. Probiotics Antimicrob Proteins. 2017;9(1):41\u20137. https:\/\/doi.org\/10.1007\/s12602-016-9233-y.","journal-title":"Probiotics Antimicrob Proteins."},{"issue":"2","key":"6113_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5681\/bi.2014.007","volume":"4","author":"M Mohamadshahi","year":"2014","unstructured":"Mohamadshahi M, Veissi M, Haidari F, Shahbazian H, Kaydani G-A, Mohammadi F. Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes. BioImpacts: BI. 2014;4(2):83\u20138. https:\/\/doi.org\/10.5681\/bi.2014.007.","journal-title":"BioImpacts: BI."},{"issue":"12","key":"6113_CR16","first-page":"1748","volume":"68","author":"M Mazani","year":"2018","unstructured":"Mazani M, Nemati A, Amani M, Haedari K, Mogadam RA, Baghi AN. The effect of probiotic yoghurt consumption on oxidative stress and inflammatory factors in young females after exhaustive exercise. JPMA J Pak Med Assoc. 2018;68(12):1748\u201354.","journal-title":"JPMA J Pak Med Assoc"},{"issue":"3","key":"6113_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/rheumatology\/37.3.274","volume":"37","author":"MT Nenonen","year":"1998","unstructured":"Nenonen MT, Helve TA, Rauma AL, H\u00e4nninen OO. Uncooked, lactobacilli-rich, vegan food and rheumatoid arthritis. Br J Rheumatol. 1998;37(3):274\u201381. https:\/\/doi.org\/10.1093\/rheumatology\/37.3.274.","journal-title":"Br J Rheumatol"},{"issue":"5","key":"6113_CR18","first-page":"S93","volume":"23","author":"J Fransen","year":"2005","unstructured":"Fransen J, Van Riel P. The Disease Activity Score and the EULAR response criteria. Clin Exper Rheumatol. 2005;23(5):S93.","journal-title":"Clin Exper Rheumatol"},{"issue":"10","key":"6113_CR19","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K","volume":"41","author":"AM van Gestel","year":"1998","unstructured":"van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum. 1998;41(10):1845\u201350. https:\/\/doi.org\/10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"6113_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"M Prevoo","year":"1995","unstructured":"Prevoo M, Van\u2019T Hof MA, Kuper H, Van Leeuwen M, Van De Putte L, Van Riel P. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44\u20138. https:\/\/doi.org\/10.1002\/art.1780380107.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"6113_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/1756-185X.12333","volume":"17","author":"B Alipour","year":"2014","unstructured":"Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, Sharif SK, Vaghef-Mehrabany L, Asghari-Jafarabadi M, et al. Effects of L actobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int J Rheum Dis. 2014;17(5):519\u201327. https:\/\/doi.org\/10.1111\/1756-185X.12333.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"6113_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.15171\/PS.2018.08","volume":"24","author":"E Vaghef-Mehrabani","year":"2018","unstructured":"Vaghef-Mehrabani E, Homayouni-Rad A, Alipour B, Vaghef-Mehrabany L, Saghafi-Asl M. Formulation and design of probiotic supplements for rheumatoid arthritis patients. Pharm Sci. 2018;24(1):44\u201351. https:\/\/doi.org\/10.15171\/PS.2018.08.","journal-title":"Pharm Sci"},{"issue":"4","key":"6113_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.nut.2013.09.007","volume":"30","author":"E Vaghef-Mehrabany","year":"2014","unstructured":"Vaghef-Mehrabany E, Alipour B, Homayouni-Rad A, Sharif S-K, Asghari-Jafarabadi M, Zavvari S. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition. 2014;30(4):430\u20135. https:\/\/doi.org\/10.1016\/j.nut.2013.09.007.","journal-title":"Nutrition."},{"issue":"9","key":"6113_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/1756-185X.12888","volume":"19","author":"B Zamani","year":"2016","unstructured":"Zamani B, Golkar HR, Farshbaf S, Emadi-Baygi M, Tajabadi-Ebrahimi M, Jafari P, et al. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Int J Rheum Dis. 2016;19(9):869\u201379. https:\/\/doi.org\/10.1111\/1756-185X.12888.","journal-title":"Int J Rheum Dis"},{"key":"6113_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7525-1-20","volume":"1","author":"B Bruce","year":"2003","unstructured":"Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes. 2003;1:20.","journal-title":"Health Qual Life Outcomes"},{"issue":"9; SUPP\/1","key":"6113_CR26","doi-asserted-by":"publisher","first-page":"S498","DOI":"10.1097\/00005768-200009001-00009","volume":"32","author":"BE Ainsworth","year":"2000","unstructured":"Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exercise. 2000;32(9; SUPP\/1):S498\u2013504.","journal-title":"Med Sci Sports Exercise"},{"issue":"9","key":"6113_CR27","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1002\/ptr.6433","volume":"33","author":"B Helli","year":"2019","unstructured":"Helli B, Shahi MM, Mowla K, Jalali MT, Haghighian HK. A randomized, triple-blind, placebo-controlled clinical trial, evaluating the sesamin supplement effects on proteolytic enzymes, inflammatory markers, and clinical indices in women with rheumatoid arthritis. Phytother Res. 2019;33(9):2421\u20138. https:\/\/doi.org\/10.1002\/ptr.6433.","journal-title":"Phytother Res"},{"issue":"1","key":"6113_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","volume":"73","author":"M Dougados","year":"2014","unstructured":"Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014;73(1):62\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204223.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"6113_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/jcm10030509","volume":"10","author":"PC Taylor","year":"2021","unstructured":"Taylor PC, Atzeni F, Balsa A, Gossec L, M\u00fcller-Ladner U, Pope J. The key comorbidities in patients with rheumatoid arthritis: a narrative review. J Clin Med. 2021;10(3):509. https:\/\/doi.org\/10.3390\/jcm10030509.","journal-title":"J Clin Med"},{"issue":"10","key":"6113_CR30","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.3390\/ijms19102938","volume":"19","author":"A Picchianti-Diamanti","year":"2018","unstructured":"Picchianti-Diamanti A, Panebianco C, Salemi S, Sorgi ML, Di Rosa R, Tropea A, et al. Analysis of gut microbiota in rheumatoid arthritis patients: disease-related dysbiosis and modifications induced by etanercept. Int J Mol Sci. 2018;19(10):2938. https:\/\/doi.org\/10.3390\/ijms19102938.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6113_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-016-0299-7","volume":"8","author":"J Chen","year":"2016","unstructured":"Chen J, Wright K, Davis JM, Jeraldo P, Marietta EV, Murray J, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 2016;8(1):1\u201314. https:\/\/doi.org\/10.1186\/s13073-016-0299-7.","journal-title":"Genome Med"},{"issue":"12","key":"6113_CR32","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41579-019-0256-8","volume":"17","author":"AA Kolodziejczyk","year":"2019","unstructured":"Kolodziejczyk AA, Zheng D, Elinav E. Diet\u2013microbiota interactions and personalized nutrition. Nat Rev Microbiol. 2019;17(12):742\u201353. https:\/\/doi.org\/10.1038\/s41579-019-0256-8.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"6113_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-014-0189-7","volume":"14","author":"SC Bischoff","year":"2014","unstructured":"Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke J-D, Serino M, et al. Intestinal permeability\u2013a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14(1):1\u201325. https:\/\/doi.org\/10.1186\/s12876-014-0189-7.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"6113_CR34","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.berh.2016.10.003","volume":"30","author":"F Ciccia","year":"2016","unstructured":"Ciccia F, Ferrante A, Guggino G, Triolo G. The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases. Best Pract Res Clin Rheumatol. 2016;30(5):889\u2013900. https:\/\/doi.org\/10.1016\/j.berh.2016.10.003.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"6113_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10238-020-00647-y","volume":"21","author":"Z Reyes-Castillo","year":"2021","unstructured":"Reyes-Castillo Z, Vald\u00e9s-Miramontes E, Llamas-Covarrubias M, Mu\u00f1oz-Valle JF. Troublesome friends within us: the role of gut microbiota on rheumatoid arthritis etiopathogenesis and its clinical and therapeutic relevance. Clin Exp Med. 2021;21(1):1\u201313. https:\/\/doi.org\/10.1007\/s10238-020-00647-y.","journal-title":"Clin Exp Med"},{"issue":"12","key":"6113_CR36","first-page":"711788","volume":"2021","author":"M Ferro","year":"1840","unstructured":"Ferro M, Charneca S, Dourado E, Guerreiro CS, Fonseca JE. Probiotic supplementation for rheumatoid arthritis: a promising adjuvant therapy in the gut microbiome era. Frontiers Pharmacol. 1840;2021(12):711788.","journal-title":"Frontiers Pharmacol."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06113-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T13:07:52Z","timestamp":1645708072000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06113-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6113"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06113-2","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"assertion":[{"value":"26 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Bioethics Committee of the Tehran University of Medical Sciences (Code: IR.TUMS.MEDICINE.REC.1399.883). All participants will sign a written informed consent form. The results of this study will be disseminated in a medical journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}